advertisement

Topcon

Oliver AL 33

Showing records 1 to 25 | Display all abstracts from Oliver AL

112886 Bilateral Acute Iris Transillumination Syndrome Following Oral Moxifloxacin Overdose
Mendez Bermudez IJ
Cureus 2023; 15: e47426
113009 Bilateral Acute Iris Transillumination Associated with Moxifloxacin Antibiotic Use
Gorbea Fuxench GA
Ocular Immunology and Inflammation 2023; 0: 1-6
113386 Instances of ocular findings in transgender patients undergoing hormonal therapy
Nieves-Ríos C
American journal of ophthalmology case reports 2023; 32: 101965
113009 Bilateral Acute Iris Transillumination Associated with Moxifloxacin Antibiotic Use
Ayala Rodríguez SC
Ocular Immunology and Inflammation 2023; 0: 1-6
113386 Instances of ocular findings in transgender patients undergoing hormonal therapy
Pulido JS
American journal of ophthalmology case reports 2023; 32: 101965
112886 Bilateral Acute Iris Transillumination Syndrome Following Oral Moxifloxacin Overdose
Ramirez Marquez E; Ramirez Marquez E
Cureus 2023; 15: e47426
113009 Bilateral Acute Iris Transillumination Associated with Moxifloxacin Antibiotic Use
Ayala Rodríguez SC; Guardiola G
Ocular Immunology and Inflammation 2023; 0: 1-6
112886 Bilateral Acute Iris Transillumination Syndrome Following Oral Moxifloxacin Overdose
Ayala Rodríguez SC; Ayala Rodríguez SC
Cureus 2023; 15: e47426
113386 Instances of ocular findings in transgender patients undergoing hormonal therapy
Thornton S
American journal of ophthalmology case reports 2023; 32: 101965
113009 Bilateral Acute Iris Transillumination Associated with Moxifloxacin Antibiotic Use
Ramos F
Ocular Immunology and Inflammation 2023; 0: 1-6
112886 Bilateral Acute Iris Transillumination Syndrome Following Oral Moxifloxacin Overdose
Ruiz-Justiz AJ
Cureus 2023; 15: e47426
113386 Instances of ocular findings in transgender patients undergoing hormonal therapy
Dunn JP; Procopio RA
American journal of ophthalmology case reports 2023; 32: 101965
113009 Bilateral Acute Iris Transillumination Associated with Moxifloxacin Antibiotic Use
Pappaterra-Rodríguez M
Ocular Immunology and Inflammation 2023; 0: 1-6
112886 Bilateral Acute Iris Transillumination Syndrome Following Oral Moxifloxacin Overdose
Rodriguez-Garcia EJ
Cureus 2023; 15: e47426
113386 Instances of ocular findings in transgender patients undergoing hormonal therapy
Oliver AL; Oliver AL
American journal of ophthalmology case reports 2023; 32: 101965
112886 Bilateral Acute Iris Transillumination Syndrome Following Oral Moxifloxacin Overdose
Gonzalez M
Cureus 2023; 15: e47426
113386 Instances of ocular findings in transgender patients undergoing hormonal therapy
Oliver AL
American journal of ophthalmology case reports 2023; 32: 101965
113009 Bilateral Acute Iris Transillumination Associated with Moxifloxacin Antibiotic Use
Requejo Figueroa GA
Ocular Immunology and Inflammation 2023; 0: 1-6
113386 Instances of ocular findings in transgender patients undergoing hormonal therapy
Lee D
American journal of ophthalmology case reports 2023; 32: 101965
113009 Bilateral Acute Iris Transillumination Associated with Moxifloxacin Antibiotic Use
Llop SM
Ocular Immunology and Inflammation 2023; 0: 1-6
112886 Bilateral Acute Iris Transillumination Syndrome Following Oral Moxifloxacin Overdose
Nieves I
Cureus 2023; 15: e47426
113009 Bilateral Acute Iris Transillumination Associated with Moxifloxacin Antibiotic Use
Santiago LA
Ocular Immunology and Inflammation 2023; 0: 1-6
113386 Instances of ocular findings in transgender patients undergoing hormonal therapy
Edwards R
American journal of ophthalmology case reports 2023; 32: 101965
112886 Bilateral Acute Iris Transillumination Syndrome Following Oral Moxifloxacin Overdose
Blasini M
Cureus 2023; 15: e47426
113009 Bilateral Acute Iris Transillumination Associated with Moxifloxacin Antibiotic Use
Santos C
Ocular Immunology and Inflammation 2023; 0: 1-6

Issue 24-3

Change Issue


advertisement

Nidek